|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-3-14
|
|
pubmed:abstractText |
To assess the efficacy of combination therapy with fludarabine and cyclophosphamide in patients with chronic lymphocytic leukemia (CLL) based on data suggesting in vitro synergistic activity of the two agents.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1414-20
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11230486-Adult,
pubmed-meshheading:11230486-Aged,
pubmed-meshheading:11230486-Aged, 80 and over,
pubmed-meshheading:11230486-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11230486-Cyclophosphamide,
pubmed-meshheading:11230486-Disease Progression,
pubmed-meshheading:11230486-Disease-Free Survival,
pubmed-meshheading:11230486-Female,
pubmed-meshheading:11230486-Flow Cytometry,
pubmed-meshheading:11230486-Humans,
pubmed-meshheading:11230486-Infusions, Intravenous,
pubmed-meshheading:11230486-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:11230486-Male,
pubmed-meshheading:11230486-Middle Aged,
pubmed-meshheading:11230486-Salvage Therapy,
pubmed-meshheading:11230486-Treatment Outcome,
pubmed-meshheading:11230486-Vidarabine
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia.
|
|
pubmed:affiliation |
Leukemia Department, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|
